About this Journal Submit a Manuscript Table of Contents
International Journal of Hepatology
Volume 2013 (2013), Article ID 928960, 5 pages
http://dx.doi.org/10.1155/2013/928960
Clinical Study

Etiologies and Outcomes of Acute Liver Failure in a Spanish Community

Gastroenterology and Hepatology Unit, University Hospital “Marqués de Valdecilla”, Instituto de Formación e Investigación Marqués de Valdecilla (IFIMAV), Avenida Valdecilla s/n., Santander, 39008 Cantabria, Spain

Received 19 May 2013; Accepted 22 July 2013

Academic Editor: Matthias Bahr

Copyright © 2013 Emilio Fábrega et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Trey and C. S. Davidson, “The management of fulminant hepatic failure,” in Progress in Liver Diseases, H. Popper and F. Schaffner, Eds., pp. 282–298, Grune & Stratton, New York, NY, USA, 1970.
  2. J. Bernuau, B. Rueff, and J. P. Benhamou, “Fulminant and subfulminant liver failure: definitions and causes,” Seminars in Liver Disease, vol. 6, no. 2, pp. 97–106, 1986. View at Scopus
  3. J. G. O'Grady, “Postoperative issues and outcome for acute liver failure.,” Liver Transplantation, vol. 14, no. supplement 2, pp. S97–S101, 2008. View at Publisher · View at Google Scholar
  4. G. Ostapowicz, R. J. Fontana, F. V. Schiodt et al., “Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States,” Annals of Internal Medicine, vol. 137, no. 12, pp. 947–954, 2002. View at Scopus
  5. Á. Escorsell, A. Mas, and M. de la Mata, “Acute liver failure in Spain: analysis of 267 cases,” Liver Transplantation, vol. 13, no. 10, pp. 1389–1395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. G. O'Grady, S. W. Schalm, and R. Williams, “Acute liver failure: redefining the syndromes,” The Lancet, vol. 342, no. 8866, pp. 273–275, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. W. M. Lee, “Acute liver failure,” The New England Journal of Medicine, vol. 329, no. 25, pp. 1862–1872, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. J. G. O'Grady, G. J. M. Alexander, K. M. Hayllar, and R. Williams, “Early indicators of prognosis in fulminant hepatic failure,” Gastroenterology, vol. 97, no. 2, pp. 439–445, 1989. View at Scopus
  9. J. Bernuau, A. Goudeau, and T. Poynard, “Multivariate analysis of prognostic factors in fulminant hepatitis B,” Hepatology, vol. 6, no. 4, pp. 648–651, 1986. View at Scopus
  10. W. M. Lee, “Recent developments in acute liver failure,” Best Practice & Research Clinical Gastroenterology, vol. 26, no. 1, pp. 3–16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Adam, V. Karam, V. Delvart, et al., “Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR),” Journal of Hepatology, vol. 57, no. 3, pp. 675–688, 2012. View at Publisher · View at Google Scholar
  12. G. Germani, E. Theocharidou, R. Adam, et al., “Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database,” Journal of Hepatology, vol. 57, no. 2, pp. 288–296, 2012. View at Publisher · View at Google Scholar
  13. S. K. Acharya, S. Dasarathy, T. L. Kumer et al., “Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome,” Hepatology, vol. 23, no. 6, pp. 1448–1455, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Oketani, A. Ido, and H. Tsubouchi, “Changing etiologies and outcomes of acute liver failure: a perspective from Japan,” Journal of Gastroenterology and Hepatology, vol. 26, no. supplement 1, pp. 65–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Bernal, T. J. S. Cross, G. Auzinger et al., “Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience,” Journal of Hepatology, vol. 50, no. 2, pp. 306–313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Rakela, J. W. Mosley, V. M. Edwards, S. Govindarajan, and E. Alpert, “A double-blinded, randomized trial of hydrocortisone in acute hepatic failure,” Digestive Diseases and Sciences, vol. 36, no. 9, pp. 1223–1228, 1991. View at Publisher · View at Google Scholar · View at Scopus
  17. R. T. Stravitz and D. J. Kramer, “Management of acute liver failure,” Nature Reviews Gastroenterology and Hepatology, vol. 6, no. 9, pp. 542–553, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Bernal, G. Auzinger, and J. Wendon, “Prognostic utility of the bilirubin lactate and etiology score,” Clinical Gastroenterology and Hepatology, vol. 7, no. 2, p. 249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Sarwar, A. A. Khan, A. Alam et al., “Predictors of fatal outcome in fulminant hepatic failure,” Journal of the College of Physicians and Surgeons Pakistan, vol. 16, no. 2, pp. 112–116, 2006. View at Scopus
  20. C. M. Chu and Y. F. Liaw, “The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state,” Infection, vol. 18, no. 4, pp. 200–203, 1990. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Polson and W. M. Lee, “Etiologies of acute liver failure: location, location, location!,” Liver Transplantation, vol. 13, no. 10, pp. 1362–1363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. E. Gulmez, D. Larrey, G. P. Pageaux, et al., “Transplantation for acute liver failure in patients exposed to NSAID sor paracetamol (acetaminophen): the multinational case-population SALT study,” Drug Safety, vol. 36, no. 2, pp. 135–144, 2013. View at Publisher · View at Google Scholar
  23. R. Jalan, R. Williams, and J. Bernuau, “Paracetamol: are therapeutic doses entirely safe?” The Lancet, vol. 368, no. 9554, pp. 2195–2196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. J. Davern II, L. P. James, J. A. Hinson et al., “Measurement of serum acetaminophen-protein adducts in patients with acute liver failure,” Gastroenterology, vol. 130, no. 3, pp. 687–694, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Ichai and D. Samuel, “Etiology and prognosis of fulminant hepatitis in adults,” Liver Transplantation, vol. 14, no. supplement 2, pp. S67–S79, 2008. View at Scopus
  26. S. E. Yantorno, W. K. Kremers, A. E. Ruf, J. J. Trentadue, L. G. Podestá, and F. G. Villamil, “MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure,” Liver Transplantation, vol. 13, no. 6, pp. 822–828, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. W. M. Lee, R. H. Squires Jr., S. L. Nyberg, E. Doo, and J. H. Hoofnagle, “Acute liver failure: summary of a workshop,” Hepatology, vol. 47, no. 4, pp. 1401–1415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. D. J. Ritt, G. Whelan, D. J. Werner, E. H. Eigenbrodt, S. Schenker, and B. Combes, “Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients,” Medicine, vol. 48, no. 2, pp. 151–172, 1969. View at Scopus
  29. J. Rakela, S. M. Lange, J. Ludwig, and W. P. Baldus, “Fulminant hepatitis: Mayo Clinic experience with 34 cases,” Mayo Clinic Proceedings, vol. 60, no. 5, pp. 289–292, 1985. View at Scopus